The February 11, 2017 program will be a presentation of highlights about Multiple Myeloma research and treatment from the recent annual ASH (American of Society of Hematology) meeting. Our speaker will be Adam D. Cohen, MD, Assistant Professor and Director of Myeloma Immunotherapy at the Abramson Cancer Center of the U of Pennsylvania.
What: Searchable Repository of Abstracts from In-person conference
When: Saturday December 9, 2017 - Tuesday December 12, 2017
More Info: https://ash.confex.com/ash/2017/webprogram/start.html
Many of us in the PMNNG consider Phil Falkowitz to be a larger-than-life inspiration. Now we can say that that is literally true.
A mural featuring a likeness of Phil is being featured at ASH 2017 by Celgene. This is a truly fitting honor for Phil because he was one of the first multiple myeloma patients to participate in a Revlimid (lenalidomide) trial. Phil also serves in Celgene's "Ambassadors" program, helping to educate other patients.
Congratulations, Phil, on this tribute. And thanks for all you do as an advocate!
What: Webcast audio (1:03:00)
When: Friday January 5, 2018
More Info: https://www.myelomacrowd.org/myeloma-2018-orlowski/
What: Webcast slides
When: Wednesday January 10, 2018
More Info: https://www.themmrf.org/wp-content/uploads/MMRF_Webinar_ASH2017_Highlights_Slides.pdf